Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1801282
rs1801282
0.070 GeneticVariation BEFREE Association between peroxisome proliferator-activated receptor γ-2 gene Pro12Ala polymorphisms and risk of hypertension: an updated meta-analysis. 30777927

2019

dbSNP: rs1801282
rs1801282
0.070 GeneticVariation BEFREE The results indicated the significant association of PPARγ2 rs1801282 polymorphism with hypertension susceptibility among East Asians. 22561695

2012

dbSNP: rs1801282
rs1801282
0.070 GeneticVariation BEFREE The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma (PPARgamma) has been associated with decreased obesity, insulin resistance, type 2 diabetes and other age-associated diseases such as cognitive impairment, hypertension, cancer, osteoarthritis. 19766907

2009

dbSNP: rs1801282
rs1801282
0.070 GeneticVariation BEFREE We randomly recruited 251 nuclear families (433 parents and 493 offspring) in the framework of the European Project on Genes in Hypertension study and genotyped 926 participants in whom all serum lipid variables and information on alcohol consumption were available for PPARgamma2 Pro12Ala. 15716591

2005

dbSNP: rs1801282
rs1801282
0.070 GeneticVariation BEFREE Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2. 15662218

2005

dbSNP: rs1801282
rs1801282
0.070 GeneticVariation BEFREE The data suggest a contribution of the Pro12Ala polymorphism of PPARgamma to genetic susceptibility to type 2 diabetes mellitus and hypertension, but not to insulin sensitivity in hypertensive subjects. 15563983

2004

dbSNP: rs1801282
rs1801282
0.070 GeneticVariation BEFREE The Pro12Ala polymorphism is not directly associated with obesity, hypertension or diabetes in this population. 11248748

2001

dbSNP: rs1805192
rs1805192
0.060 GeneticVariation BEFREE Association between peroxisome proliferator-activated receptor γ-2 gene Pro12Ala polymorphisms and risk of hypertension: an updated meta-analysis. 30777927

2019

dbSNP: rs1805192
rs1805192
0.060 GeneticVariation BEFREE The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma (PPARgamma) has been associated with decreased obesity, insulin resistance, type 2 diabetes and other age-associated diseases such as cognitive impairment, hypertension, cancer, osteoarthritis. 19766907

2009

dbSNP: rs1805192
rs1805192
0.060 GeneticVariation BEFREE We randomly recruited 251 nuclear families (433 parents and 493 offspring) in the framework of the European Project on Genes in Hypertension study and genotyped 926 participants in whom all serum lipid variables and information on alcohol consumption were available for PPARgamma2 Pro12Ala. 15716591

2005

dbSNP: rs1805192
rs1805192
0.060 GeneticVariation BEFREE Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2. 15662218

2005

dbSNP: rs1805192
rs1805192
0.060 GeneticVariation BEFREE The data suggest a contribution of the Pro12Ala polymorphism of PPARgamma to genetic susceptibility to type 2 diabetes mellitus and hypertension, but not to insulin sensitivity in hypertensive subjects. 15563983

2004

dbSNP: rs1805192
rs1805192
0.060 GeneticVariation BEFREE The Pro12Ala polymorphism is not directly associated with obesity, hypertension or diabetes in this population. 11248748

2001

dbSNP: rs1175543
rs1175543
0.010 GeneticVariation BEFREE Moreover, among the eight SNPs not individually associated with hypertension (rs12631819, rs2920502, rs1175543, and rs2972164 in the PPARG gene, and rs2638360, rs1492100, rs5182, and rs275646 in the AGTR1 gene), the two-locus model involving rs12631819 and rs5182 demonstrated increased susceptibility to hypertension, and the five-locus model involving rs12631819, rs2920502, rs2972164, rs5182, and rs2638360 demonstrated a significantly decreased risk of hypertension. 29266977

2018

dbSNP: rs12631819
rs12631819
0.010 GeneticVariation BEFREE Moreover, among the eight SNPs not individually associated with hypertension (rs12631819, rs2920502, rs1175543, and rs2972164 in the PPARG gene, and rs2638360, rs1492100, rs5182, and rs275646 in the AGTR1 gene), the two-locus model involving rs12631819 and rs5182 demonstrated increased susceptibility to hypertension, and the five-locus model involving rs12631819, rs2920502, rs2972164, rs5182, and rs2638360 demonstrated a significantly decreased risk of hypertension. 29266977

2018

dbSNP: rs2972164
rs2972164
0.010 GeneticVariation BEFREE Moreover, among the eight SNPs not individually associated with hypertension (rs12631819, rs2920502, rs1175543, and rs2972164 in the PPARG gene, and rs2638360, rs1492100, rs5182, and rs275646 in the AGTR1 gene), the two-locus model involving rs12631819 and rs5182 demonstrated increased susceptibility to hypertension, and the five-locus model involving rs12631819, rs2920502, rs2972164, rs5182, and rs2638360 demonstrated a significantly decreased risk of hypertension. 29266977

2018

dbSNP: rs3856806
rs3856806
0.010 GeneticVariation BEFREE MB-MDR analyses suggested that the two-locus model (rs9817428 and rs2933249) and the three-locus model (rs9817428, rs3856806, and rs2933249) were significantly associated with a decreased risk of hypertension. 29266977

2018

dbSNP: rs9817428
rs9817428
0.010 GeneticVariation BEFREE MB-MDR analyses suggested that the two-locus model (rs9817428 and rs2933249) and the three-locus model (rs9817428, rs3856806, and rs2933249) were significantly associated with a decreased risk of hypertension. 29266977

2018

dbSNP: rs12633551
rs12633551
0.010 GeneticVariation BEFREE The SNP rs6802898 was associated with hypertension in both dominant (P = 0.033) and additive models (P = 0.026) in the Han population, whereas the SNP rs12633551 was associated with hypertension in both dominant (P = 0.014) and additive models (P = 0.0073) in the Mongolian population. 26782582

2015

dbSNP: rs6802898
rs6802898
0.010 GeneticVariation BEFREE The SNP rs6802898 was associated with hypertension in both dominant (P = 0.033) and additive models (P = 0.026) in the Han population, whereas the SNP rs12633551 was associated with hypertension in both dominant (P = 0.014) and additive models (P = 0.0073) in the Mongolian population. 26782582

2015

dbSNP: rs121909244
rs121909244
0.010 GeneticVariation BEFREE A dominant negative P467L mutation in the ligand-binding domain of PPARgamma in humans is associated with severe insulin resistance and hypertension. 15254591

2004